583840-04-4

Basic information

• Product Name: Sorafenib Impurity 13
• Synonyms: Sorafenib Impurity 13;N-Desmethyl Sorafenib (Pyridine)-N-oxide
• CAS NO: 583840-04-4
• Molecular Formula: C₂₀H₁₄ClF₃N₄O₄
• Molecular Weight: 466.7977696
• Mol File: 583840-04-4.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Sorafenib Impurity 13(CAS DataBase Reference)
• NIST Chemistry Reference: Sorafenib Impurity 13(583840-04-4)
• EPA Substance Registry System: Sorafenib Impurity 13(583840-04-4)

Safety Data

• Hazardous Substances Data: 583840-04-4(Hazardous Substances Data)

Usage

Uses

N-Desmethyl Sorafenib (Pyridine)-N-oxide is a metabolite of Sorafenib (S676850) and has anti-proliferative activity in human breast cancer cells.

Upstream product

• 284461-74-1 4-{4-[({[4-chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)amino]phenoxy}-2-pyridine carboxamide 

Relevant articles and documents

Aryl ureas as kinase inhibitors

This invention relates to new aryl ureas and methods for their synthesis. The inventive compounds are useful in the treatment of (i) raf mediated diseases, for example, cancer, (ii) p38 mediated diseases such as inflammation and osteoporosis, and (iii) VE

Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitors

This invention relates to urea compounds containing a pyridine, quinoline, or isoquinoline functionality which is oxidized at the nitrogen heteroatom and which are useful in the treatment of (i) raf mediated diseases, for example, cancer, (ii) p38 mediated diseases such as inflammation and osteoporosis, and (iii) VEGF mediated diseases such as angiogenesis disorders.